Compositions and methods related to tumor activated molecules targeting nectin-4 and effector cell antigens

TW202637584APending Publication Date: 2026-09-16MERCK SHARP & DOHME CORP +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114149129
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-17
Filing Date
2025-12-15
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001076756_001
    Figure TWG2TA001076756_001
  • Figure TWG2TA001076756_002
    Figure TWG2TA001076756_002
  • Figure TWG2TA001076756_003
    Figure TWG2TA001076756_003
Patent Text Reader

Abstract

Disclosed herein are polypeptides and polypeptide complexes that are capable of binding tumor cell antigens and effector cell antigens. In some embodiments, the polypeptides and polypeptide complexes bind the tumor cell antigens and the effector cell antigens in a tumor microenvironment.
Need to check novelty before this filing date? Find Prior Art